A detailed history of Sweet Financial Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sweet Financial Partners, LLC holds 5,354 shares of MRK stock, worth $552,104. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,354
Previous 7,868 31.95%
Holding current value
$552,104
Previous $974,000 37.58%
% of portfolio
0.14%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$111.15 - $128.97 $279,431 - $324,230
-2,514 Reduced 31.95%
5,354 $608,000
Q2 2024

Jul 18, 2024

SELL
$123.8 - $132.96 $303,433 - $325,884
-2,451 Reduced 23.75%
7,868 $974,000
Q1 2024

Apr 23, 2024

SELL
$113.24 - $131.95 $1.47 Million - $1.71 Million
-12,973 Reduced 55.7%
10,319 $1.36 Million
Q4 2023

Jan 12, 2024

BUY
$100.18 - $109.02 $284,210 - $309,289
2,837 Added 13.87%
23,292 $2.54 Million
Q3 2023

Oct 23, 2023

BUY
$102.95 - $114.33 $133,011 - $147,714
1,292 Added 6.74%
20,455 $2.11 Million
Q2 2023

Jul 24, 2023

BUY
$108.61 - $118.38 $329,848 - $359,520
3,037 Added 18.83%
19,163 $2.21 Million
Q1 2023

Apr 14, 2023

BUY
$102.94 - $114.86 $248,188 - $276,927
2,411 Added 17.58%
16,126 $1.72 Million
Q4 2022

Jan 19, 2023

BUY
$87.44 - $112.11 $86,827 - $111,325
993 Added 7.81%
13,715 $0
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $550,036 - $617,904
6,507 Added 104.7%
12,722 $1.1 Million
Q2 2022

Aug 03, 2022

SELL
$83.49 - $94.64 $17,365 - $19,685
-208 Reduced 3.24%
6,215 $567,000
Q1 2022

Apr 22, 2022

BUY
$73.51 - $82.4 $11,247 - $12,607
153 Added 2.44%
6,423 $527,000
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $453,195 - $567,685
6,270 New
6,270 $481,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sweet Financial Partners, LLC Portfolio

Follow Sweet Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweet Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweet Financial Partners, LLC with notifications on news.